POSA207 Expert Consensus on Payment Models for Multi-Indication Therapies

Cole, A ; Neri, M ; Aaviksoo, A ; Grueger, J ; Pani, L ; Pita Barros, P ; Towse, A ; Wong-Rieger, D ; Conge, M ; Horsfield, A ; Cookson, G

Elsevier Inc

Texto completo disponível

PCN182 A Partial Mcda Approach to Identify Key Criteria for Brazilian Public Reimbursement Decision in Melanoma Adjuvant Treatment Setting

Murta Amaral, L. ; Barros, M. ; Freitas, G. ; Martins, C. ; Rovere, R. ; Oliveira, M. ; Girola, N. ; Sallum, F. ; Arinelli, R. ; Pepe, C. ; Salgado, J.

Elsevier Inc

Texto completo disponível

Cost-Effectiveness Analysis Of Pharmaceutical Care For Type 2 Diabetes Mellitus Pacients In Ribeirão Preto Brazil

Picoli, RM ; Pereira, LB ; Barros, MT ; Nunes, AA ; Pereira, LR ; Costa, AL

Texto completo disponível

PHS44 - Cost-Effectiveness Analysis Of Pharmaceutical Care For Type 2 Diabetes Mellitus Pacients In Ribeirão Preto Brazil

Picoli, RM ; Pereira, LB ; Barros, MT ; Nunes, AA ; Pereira, LR ; Costa, AL

Elsevier Inc

Texto completo disponível

Programa Stewardship: Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

Reis, HP ; Castro, K ; Andrade, CC ; Neto, JA ; Barros, A ; Rodrigues, JL ; Girao, ES ; Pontes, LB ; Pitta, A ; Fonteles, MM ; Ponciano, AM

Texto completo disponível

PGI18 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPE I CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

Barros, FMR ; Cheinquer, H ; Borges, LG ; Santos, E

Elsevier Inc

Texto completo disponível

PGI19 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PRIVATE PAYER PERSPECTIVE IN BRAZIL

Barros, FMR ; Cheinquer, H ; Borges, LG ; Santos, E

Elsevier Inc

Texto completo disponível

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE EFFECTS OF THERAPY WITH PEGINTERFERON-ALPHA-2A VERSUS STANDARD-DOSE PEGINTERFERON-ALPHA-2B? A META-ANALYSIS COMPARING BOTH TREATMENTS PLUS RIBAVIRIN IN GENOTYPE 1/4 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION PATIENTS

Barros, FMR ; Cheinquer, H ; Borges, LG ; Santos, E

Elsevier Inc

Texto completo disponível

PGI17 COST-EFFECTIVENESS ANALYSIS OF TREATMENT WITH PEGINTERFERON-ALFA-2A VERSUS PEGINTERFERON-ALFA-2B FOR PATIENTS WITH GENOTYPES 2/3 CHRONIC HEPATITIS C UNDER THE PUBLIC PAYER PERSPECTIVE IN BRAZIL

Barros, FMR ; Cheinquer, H ; Borges, LG ; Santos, E

Elsevier Inc

Texto completo disponível

PGI4 SYSTEMATIC REVIEW AND META-ANALYSIS OF PUBLISHED RANDOMIZED CONTROLLED TRIALS COMPARING THE EFFICACY OF PEGINTERFERON-ALPHA-2A VERSUS PEGINTERFERON ALPHA-2B BOTH PLUS RIBAVIRIN IN CHRONIC HEPATITIS C PATIENTS

Cheinquer, H ; Barros, FMR ; Borges, LG ; Santos, E ; Buschinelli, CT

Elsevier Inc

Texto completo disponível